| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/11/2001 | EP1090924A1 Tumor antigen peptides originating in cyclophilin b |
| 04/11/2001 | EP1090146A1 Uses of dna-pk |
| 04/11/2001 | EP1090122A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 04/11/2001 | EP1090115A2 Modularly constructed rna molecules having two sequence region types |
| 04/11/2001 | EP1090114A2 Structured antisense nucleic acid molecules |
| 04/11/2001 | EP1090110A2 Human vault rna |
| 04/11/2001 | EP1090025A1 Antisense modulation of tnfr1 expression |
| 04/11/2001 | EP1089764A2 A method for stimulating the immune system |
| 04/11/2001 | EP0963203A4 Mammalian tolloid-like gene and protein |
| 04/11/2001 | EP0876492A4 Novel methods for the characterization of compounds which stimulate stf-1 expression in pancreatic islet cells |
| 04/11/2001 | EP0779929B1 Non self-inactivating, expression targeted retroviral vectors |
| 04/11/2001 | CN1291235A Vaccines immunotherapeutics and method for using the same |
| 04/11/2001 | CN1291231A Human telomerase catalytic subunit |
| 04/11/2001 | CN1291230A Biotin-binding receptor molecules |
| 04/10/2001 | US6215039 Immunosuppressed non-human mammal having exogenous germ cells in its native seminiferous tubules which produce spermatozoa capable of fertilizing ova; for producing germ cells; gene therapy |
| 04/10/2001 | US6214986 Antisense modulation of bcl-x expression |
| 04/10/2001 | US6214974 Internalizable cell binding component having biotin binding element conjugated to biotinylated nucleic acids or cytotoxic moieties such as gelonin, ricin, saporin, abrin, diptheria toxin and the like; gene therapy; drug delivery of toxins |
| 04/10/2001 | US6214970 Hepatitis E virus antigens and uses therefor |
| 04/10/2001 | US6214805 Genes, gene signals, genomes rna strands and respiratory syncytial virus with promoters |
| 04/10/2001 | US6214804 Producing antibodies directed to protein of hiv virus in mice, dna plasmids |
| 04/10/2001 | US6214622 Targeted introduction of DNA into primary or secondary cells and their use for gene therapy |
| 04/10/2001 | US6214620 Inducible genetic suppression of cellular excitability |
| 04/10/2001 | US6214614 Cell cycle regulated repressor and DNA element |
| 04/10/2001 | US6214600 Polypeptide of defined amino acid sequence; treatment of alzheimer's disease, stroke, musculoskeletal disease, heart disease, kidney disease; anticarcinogenic/antiinflammatory agents; antiarthritic agents; diagnosis |
| 04/10/2001 | US6214595 Enzymatic polypeptide for utilization in screening bactericides; wound healing agents; for prevent of bacterial wound infections |
| 04/10/2001 | US6214562 Transcriptionally regualted G protein-coupled receptor |
| 04/10/2001 | US6214543 DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 04/10/2001 | US6214540 Chemokines that inhibit immunodeficiency virus infection and methods based thereon |
| 04/10/2001 | US6214355 DbpA compositions |
| 04/10/2001 | US6214348 Administering to the mammal a polypeptide comprising seq id no:2 in an amount sufficient to induce an immunological response to produce antibodies to seq id no:2 |
| 04/10/2001 | US6214346 Bactericides |
| 04/10/2001 | US6214334 Integrating postmitotic human nt2n neurons (teratocarcinoma cell line (nt2) neurons) into the spinal cord of a mammal by implanting into the spinal cord |
| 04/10/2001 | US6214333 Vasoprotective recombinant adenovirus vector containing a human TFPI gene |
| 04/07/2001 | CA2320400A1 Gene necessary for striatal function and uses thereof, and compounds for modulating same |
| 04/05/2001 | WO2001023604A2 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 04/05/2001 | WO2001023599A1 Streptococcus pneumoniae ykqc |
| 04/05/2001 | WO2001023598A1 41 human secreted proteins |
| 04/05/2001 | WO2001023597A2 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/05/2001 | WO2001023590A2 22196, a novel human aminopeptidase |
| 04/05/2001 | WO2001023588A1 Human carboxypeptidases and polynucleotides encoding the same |
| 04/05/2001 | WO2001023587A2 Serine protease |
| 04/05/2001 | WO2001023584A1 Human ubiquitin protease |
| 04/05/2001 | WO2001023577A2 Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis b virus sequences |
| 04/05/2001 | WO2001023572A2 Polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | WO2001023565A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | WO2001023554A1 The prv-1 gene and use thereof |
| 04/05/2001 | WO2001023550A2 Pca3 messenger rna species in benign and malignant prostate tissues |
| 04/05/2001 | WO2001023547A1 26 human secreted proteins |
| 04/05/2001 | WO2001023546A1 37 human secreted proteins |
| 04/05/2001 | WO2001023545A1 Dna containing variant frt sequences |
| 04/05/2001 | WO2001023540A2 P-glycoproteins and uses thereof |
| 04/05/2001 | WO2001023537A1 Process for enhancing electric field-mediated delivery of biological materials into cells |
| 04/05/2001 | WO2001023522A2 Compositions and methods for p53-mediated repression of gene expression |
| 04/05/2001 | WO2001023427A1 Polypeptide derivatives of parathyroid hormone (pth) |
| 04/05/2001 | WO2001023423A1 A novel gene encodes the human huntingtin interacting polypeptide which comprises the ww domain and its producing method and application |
| 04/05/2001 | WO2001023421A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/05/2001 | WO2001023416A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 04/05/2001 | WO2001023409A2 38 human secreted proteins |
| 04/05/2001 | WO2001023402A1 43 human secreted proteins |
| 04/05/2001 | WO2001023004A1 Replication selective adenoviruses for use in cancer therapy |
| 04/05/2001 | WO2001023003A1 Tissue flap angiogenesis |
| 04/05/2001 | WO2001023002A1 Method for inhibition of pathogenic microorganisms |
| 04/05/2001 | WO2001023001A2 Rapid peg-modification |
| 04/05/2001 | WO2001022987A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 04/05/2001 | WO2001022972A2 Immunostimulatory nucleic acids |
| 04/05/2001 | WO2001022950A2 Diosolane nucleoside analogs for the treatment or prevention of viral infection |
| 04/05/2001 | WO2001011369A8 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 04/05/2001 | WO2001006015A8 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 04/05/2001 | WO2000069455A3 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 04/05/2001 | WO2000066752A3 Gene construct for prodrug activation encoding a heterologous, glycosylphophati dylinositol-modified carboypeptidase g2 and a cell surface targettng signal peptide |
| 04/05/2001 | WO2000061617A3 Transiently immortalized cells for use in gene therapy |
| 04/05/2001 | WO2000060051A8 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 04/05/2001 | WO2000056891A3 Human transmembrane proteins |
| 04/05/2001 | WO2000055343A3 Retrovirus producting cells utilizing a high multiplicity of transduction |
| 04/05/2001 | WO2000052205A3 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 04/05/2001 | WO2000030668A9 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 04/05/2001 | WO2000029578A9 Cloning and characterization of two m-rna transcription factors |
| 04/05/2001 | WO2000020450A9 Calcium channel alpha-2/delta gene |
| 04/05/2001 | US20010000176 Overcoming maternal immunity interference to a vaccine in a mammalian infant under one year of age inducing a protective immune by administering a transcribable polynucleotide sequence encoding an antigen of a pathogenic organism |
| 04/05/2001 | DE19947010A1 Das Gen PRV-1 und dessen Verwendung The PRV-1 gene and its use |
| 04/05/2001 | CA2811455A1 Highly conserved genes and their use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical microorganisms from clinical specimens for diagnosis |
| 04/05/2001 | CA2390716A1 Process for enhancing electric field-mediated delivery of biological materials into cells |
| 04/05/2001 | CA2388461A1 Highly conserved genes and their use to generate probes and primers for the detection of microorganisms |
| 04/05/2001 | CA2388055A1 Immunostimulatory nucleic acids |
| 04/05/2001 | CA2387702A1 The prv-1 gene and use thereof |
| 04/05/2001 | CA2386346A1 Novel polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | CA2386077A1 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 04/05/2001 | CA2386032A1 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/05/2001 | CA2386029A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | CA2386002A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 04/05/2001 | CA2385884A1 26 human secreted proteins |
| 04/05/2001 | CA2385883A1 Human carboxypeptidases and polynucleotides encoding the same |
| 04/05/2001 | CA2385349A1 Method for the treatment or prevention of viral infection using nucleoside analogues |
| 04/05/2001 | CA2385169A1 43 human secreted proteins |
| 04/05/2001 | CA2384981A1 P-glycoproteins and uses thereof |
| 04/05/2001 | CA2384814A1 Methods for rapid peg-modification of viral vectors, compositions for enhanced gene transduction, compositions with enhanced physical stability, and uses therefor |
| 04/05/2001 | CA2384662A1 41 human secreted proteins |
| 04/05/2001 | CA2384659A1 37 human secreted proteins |
| 04/05/2001 | CA2384584A1 38 human secreted proteins |
| 04/05/2001 | CA2384382A1 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |